These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16542291)

  • 1. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
    Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
    Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
    BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FibroTest-ActiTest for predicting liver fibrosis and inflammatory activity in Chinese patients with chronic hepatitis B].
    Gui HL; Xie Q; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):897-901. PubMed ID: 19105932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
    Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
    Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
    Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
    Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
    Myers RP; Tainturier MH; Ratziu V; Piton A; Thibault V; Imbert-Bismut F; Messous D; Charlotte F; Di Martino V; Benhamou Y; Poynard T
    J Hepatol; 2003 Aug; 39(2):222-30. PubMed ID: 12873819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.
    Kim BK; Kim SU; Kim HS; Park JY; Ahn SH; Chon CY; Cho IR; Joh DH; Park YN; Han KH; Kim DY
    PLoS One; 2012; 7(4):e35825. PubMed ID: 22536445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
    Castéra L; Vergniol J; Foucher J; Le Bail B; Chanteloup E; Haaser M; Darriet M; Couzigou P; De Lédinghen V
    Gastroenterology; 2005 Feb; 128(2):343-50. PubMed ID: 15685546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
    Park MS; Kim BK; Cheong JY; Kim DJ; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Kim SU
    PLoS One; 2013; 8(2):e55759. PubMed ID: 23405210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
    Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
    J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
    Ngo Y; Munteanu M; Messous D; Charlotte F; Imbert-Bismut F; Thabut D; Lebray P; Thibault V; Benhamou Y; Moussalli J; Ratziu V; Poynard T
    Clin Chem; 2006 Oct; 52(10):1887-96. PubMed ID: 16931569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.
    Salkic NN; Jovanovic P; Hauser G; Brcic M
    Am J Gastroenterol; 2014 Jun; 109(6):796-809. PubMed ID: 24535095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.